Skip to main content
. Author manuscript; available in PMC: 2020 Jul 19.
Published in final edited form as: Public Health Genomics. 2019 Jul 19;21(5-6):228–237. doi: 10.1159/000501464

Table 3:

Alzheimer’s genetics Quality of Informed Consent (QUIC) Privacy and genetic items survey responses.

Question Construct Strongly
Agree
Agree Not sure Disagree Strongly
Disagree
Missing Item Score
N (%) N (%) N (%) N (%) N (%) N (%) Mean
(SD)
I am concerned about the privacy and confidentiality of my genetic information P 29 (5.8) 163 (32.5) 63 (12.5) 167 (33.3) 63 (12.5) 17 (3.4) 46.08 (46.52)
Concerns about privacy would prevent me from participating in genetic research P 8 (1.6) 25 (5.0) 91 (18.1) 229 (45.6) 136 (27.1) 13 (2.6) 16.05 (29.73)
I am okay with my genetic information being shared without my direct involvement. G 89 (17.7) 270 (53.8) 77 (15.3) 31 (6.2) 18 (3.6) 17 (3.4) 18.04 (32.92)
I would prefer to have my genetic information “open access” to allow maximal use of my genetic information for Alzheimer’s research. G 114 (22.7) 217 (43.2) 79 (15.7) 53 (10.6) 24 (4.8) 15 (3.0) 23.92 (37.64)
I would prefer to have my genetic information “restricted access” to allow only NIH approved researchers to use my genetic information for Alzheimer’s research. G 45 (9.0) 153 (30.5) 67 (13.3) 179 (35.7) 41 (8.2) 17 (3.4) 47.73 (46.41)
I am okay with the researchers sharing my genetic information with “for-profit” drug companies. G 43 (8.6) 177 (35.3) 117 (23.3) 94 (18.7) 59 (11.8) 12 (2.4) 43.16 (43.13)
I am okay with researchers making a profit from my genetic information without receiving any profits myself. G 47 (9.4) 219 (43.6) 104 (20.7) 70 (13.9) 47 (9.4) 15 (3.0) 34.70 (41.66)
Once I provide genetic samples I would like them to be used indefinitely to maximize their utility. G 178 (35.5) 254 (50.6) 47 (9.4) 8 (1.6) 6 (1.2) 9 (1.8) 7.61 (2.57)

Note: Bold items reflect responses that indicate concerns with privacy or use genetic information.

P = Privacy Concerns

G = Genetic Concerns